Eupraxia Pharmaceuticals Inc
EPRX5.380USD
+0.120+2.28%
Close 08/04, 16:00（ET）Quotes delayed by 15 min
5.380USD+5.380After-hours (ET)
192.87MMarket Cap
LossP/E TTM
Eupraxia Pharmaceuticals Inc
5.380
+0.120+2.28%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q1
FY2019Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
1.92%-6.00M
-0.13%-5.97M
-71.41%-10.19M
-80.53%-7.71M
-34.01%-6.12M
---5.96M
-31.92%-5.94M
-46.33%-4.27M
-48.93%-4.57M
-128.69%-4.51M
15.26%-2.92M
11.22%-3.07M
-3236.77%-2.82M
---1.97M
---3.45M
-1019.75%-3.45M
89.39%-84.47K
--375.57K
---796.25K
Net income from continuing operations
-9.91%-6.77M
28.99%-7.53M
-22.37%-5.99M
36.21%-6.06M
-55.63%-6.16M
---10.61M
-33.24%-4.90M
-93.15%-9.51M
-33.29%-3.96M
9.92%-3.67M
-8.11%-4.92M
57.59%-2.97M
-2692.83%-3.00M
---4.08M
---4.55M
-336.16%-7.00M
80.13%-107.30K
---1.60M
---540.09K
Operating gains losses
86.40%46.49K
30.50%40.02K
-11.01%24.91K
-11.89%24.16K
-6.95%24.94K
--30.67K
-26.79%27.99K
-28.45%27.42K
-13.75%26.80K
62.80%38.23K
131.87%38.32K
94.45%31.08K
92.97%32.85K
--23.48K
--16.53K
-58.72%15.98K
-57.93%17.02K
--38.72K
--40.46K
Other non-cash items
-144.83%-70.55K
-9.75%-71.19K
199.38%6.74K
965.31%55.09K
1858.76%157.39K
---64.86K
97.02%-6.78K
93.32%-6.37K
-116.91%-8.95K
-102.45%-227.37K
-130.36%-95.37K
-96.54%52.92K
4089092.59%31.38K
---112.31K
--314.13K
--1.53M
100.06%0.77
--0.00
---1.32K
Change in working capital
-382.83%-707.40K
-89.69%568.72K
-1769.99%-4.74M
-392.93%-2.84M
117.63%250.11K
--5.52M
128.61%283.77K
-41.27%971.06K
-77.86%-1.42M
-160.18%-991.85K
720.55%1.65M
46.03%-797.79K
-30.92%-525.31K
--1.65M
--201.50K
-228.46%-1.48M
33.16%-401.25K
--1.15M
---600.28K
-Change in receivables
-150.43%-8.68K
-47.09%-182.69K
382.61%50.43K
-62.70%13.67K
919.02%17.20K
---124.21K
-66.49%-17.84K
-22.75%36.65K
128.76%1.69K
78.20%-10.72K
-86.71%47.45K
-105.25%-5.87K
43.63%-259.69K
---49.17K
--356.89K
-88.73%111.76K
51.21%-460.70K
--991.48K
---944.16K
-Change in prepaid expenses
56.26%195.64K
-1907.53%-119.41K
-198.29%-69.46K
-270.84%-884.75K
143.49%125.20K
---5.95K
-37.00%70.67K
-16.13%-238.58K
32303.54%51.42K
-35.10%112.17K
-218.07%-205.45K
100.07%158.69
10105.65%179.17K
--172.84K
---64.59K
-4902.91%-236.04K
-97.15%1.76K
--4.91K
--61.52K
-Change in payables and accrued expense
-930.33%-894.36K
-84.58%870.82K
-2143.74%-4.72M
-268.24%-1.97M
107.32%107.71K
--5.65M
121.12%230.95K
-35.24%1.17M
-85.85%-1.47M
-171.71%-1.09M
2094.85%1.81M
41.50%-792.08K
-236.08%-444.80K
--1.52M
---90.80K
-977.19%-1.35M
15.76%326.86K
--154.35K
--282.37K
Cash from non-recurring investing activities
Cash from operating activities
1.92%-6.00M
-0.13%-5.97M
-71.41%-10.19M
-80.53%-7.71M
-34.01%-6.12M
---5.96M
-31.92%-5.94M
-46.33%-4.27M
-48.93%-4.57M
-128.69%-4.51M
15.26%-2.92M
11.22%-3.07M
-3236.77%-2.82M
---1.97M
---3.45M
-1019.75%-3.45M
89.39%-84.47K
--375.57K
---796.25K
Investing cash flow
Net cash from continuing investing activities
2389.97%169.04K
-11.40%43.76K
340.27%42.27K
-379.37%-17.66K
-15.85%6.79K
--49.38K
-75.32%9.60K
-95.12%6.32K
50.79%8.07K
-88.01%38.91K
11844.70%129.56K
78.29%5.35K
--14.34K
--324.46K
--1.08K
111.45%3.00K
--0.00
---26.22K
--0.00
Capital expenditures
2389.97%169.04K
-10.27%44.31K
340.27%42.27K
71.59%10.85K
-15.85%6.79K
--49.38K
-75.32%9.60K
-95.13%6.32K
50.79%8.07K
-88.01%38.91K
11867.10%129.80K
78.29%5.35K
--14.34K
--324.46K
--1.08K
--3.00K
--0.00
--0.00
--0.00
Net cash flow from disposal of fixed assets
2389.97%169.04K
-11.40%43.76K
340.27%42.27K
-379.37%-17.66K
-15.85%6.79K
--49.38K
-75.32%9.60K
-95.12%6.32K
50.79%8.07K
-88.01%38.91K
11844.70%129.56K
78.29%5.35K
--14.34K
--324.46K
--1.08K
111.45%3.00K
--0.00
---26.22K
--0.00
Net cash flow from investment products
----
----
----
----
----
----
----
----
----
--0.00
---7.05M
----
---7.14M
----
----
----
----
----
----
Net cash flow from other investing activities
----
----
----
----
----
----
----
----
----
-100.00%0.00
--0.00
100.00%0.00
--3.44K
--32.60K
--0.00
-9364.72%-4.00M
100.00%0.00
---42.25K
---73.44K
Cash from non-current investing activities
Net cash flow from investing activities
-2389.97%-169.04K
11.40%-43.76K
-340.27%-42.27K
379.37%17.66K
15.85%-6.79K
---49.38K
75.32%-9.60K
99.91%-6.32K
-50.79%-8.07K
86.67%-38.91K
-661543.71%-7.18M
99.87%-5.35K
---7.15M
---291.86K
---1.08K
-24865.32%-4.00M
100.00%0.00
---16.03K
---73.44K
Financing cash flow
Cash flow from continuous financing activities
-98.14%429.92K
532658.26%31.73M
-128.25%-4.60M
-198.01%-4.50M
11797.52%23.15M
--5.96K
45515.00%16.29M
-55.80%4.59M
645.93%194.61K
-111.31%-35.86K
37.90%10.39M
-100.11%-35.65K
9.26%-117.58K
--317.06K
--7.53M
4237.05%31.91M
-115.54%-129.58K
---771.33K
--833.92K
Net cash flow from debt Issuance/repayment
----
100.00%0.00
-22915.61%-4.60M
-127324.75%-4.50M
-3.36%-36.82K
---20.30K
44.26%-19.99K
90.07%-3.53K
0.08%-35.62K
-111.31%-35.86K
-100.47%-35.55K
-101.78%-35.65K
-261.06%-82.89K
--317.06K
--7.53M
359.05%2.00M
-93.83%51.47K
---771.33K
--833.92K
Net cash flow from common stock issuance/repurchase
----
--31.71M
-100.00%0.00
--0.00
--22.85M
--0.00
--15.89M
-100.00%0.00
--0.00
--0.00
--10.42M
----
--30.01M
----
----
----
----
----
----
Proceeds from stock option exercised by employees
96450.00%13.52K
-3.90%25.23K
100.00%0.00
-100.00%0.00
-97.98%14.00
--26.25K
---1.00
--3.11K
--694.00
----
----
----
----
----
----
----
----
----
----
Proceeds from issuance of warrants
23.50%416.41K
63300.00%632.00
-100.00%0.00
-100.00%0.00
46.90%337.18K
---1.00
--421.00K
--4.59M
--229.54K
----
----
----
----
----
----
----
----
----
----
Net cash flow from other financing activities
----
----
----
----
----
----
----
----
----
--0.00
--0.00
-100.00%0.00
-16497.33%-30.05M
--0.00
--0.00
--29.91M
---181.04K
--0.00
----
Net cash from non-recurrent financing activities
Net cash from financing activities
-98.14%429.92K
532658.26%31.73M
-128.25%-4.60M
-198.01%-4.50M
11797.52%23.15M
--5.96K
45515.00%16.29M
-55.80%4.59M
645.93%194.61K
-111.31%-35.86K
37.90%10.39M
-100.11%-35.65K
9.26%-117.58K
--317.06K
--7.53M
4237.05%31.91M
-115.54%-129.58K
---771.33K
--833.92K
Net cash flow
Beginning cash balance
71.14%33.10M
-64.74%8.66M
61.66%23.32M
157.81%35.91M
5.90%19.34M
--24.56M
14.65%14.42M
6.20%13.93M
9.26%18.26M
-55.79%12.58M
-47.76%13.11M
13882.05%16.71M
7805.82%26.65M
--28.46M
--25.11M
-85.46%119.55K
-63.62%337.06K
--822.31K
--926.59K
Current period cash flow changes
-134.09%-5.65M
568.04%24.44M
-244.51%-14.65M
-2643.39%-12.59M
482.08%16.57M
---5.22M
336.76%10.14M
23.45%495.06K
-36.91%-4.34M
-123.81%-4.28M
-90.06%401.04K
-112.95%-3.17M
-4634.67%-10.13M
---1.91M
--4.04M
6038.59%24.45M
-498.43%-214.04K
---411.78K
---35.77K
Effect of exchange rate changes
120.73%95.50K
-262.18%-1.28M
192.83%178.85K
-317.86%-397.62K
-1122.24%-460.76K
--786.49K
-164.69%-192.68K
65.63%182.51K
176.20%45.07K
844.82%297.84K
320.20%110.19K
---59.15K
---47.45K
--31.52K
---50.04K
----
----
----
----
Ending cash balance
-23.54%27.45M
71.14%33.10M
-64.74%8.66M
61.66%23.32M
157.81%35.91M
--19.34M
187.72%24.56M
6.74%14.42M
3.12%13.93M
-67.85%8.54M
-53.58%13.51M
-45.49%13.51M
13922.10%16.54M
--26.56M
--29.11M
5671.50%24.78M
-86.75%117.93K
--429.31K
--890.25K
Free cash flow
-0.73%-6.17M
-0.04%-6.02M
-71.84%-10.23M
-80.51%-7.72M
-33.92%-6.13M
---6.01M
-31.00%-5.95M
-40.31%-4.28M
-48.94%-4.58M
-98.05%-4.55M
11.52%-3.05M
11.14%-3.07M
-3253.75%-2.83M
---2.29M
---3.45M
-1020.55%-3.46M
89.39%-84.47K
--375.57K
---796.25K
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
